Future of heart medicine: Stem cells to grow cardiac muscle and smaller medical implants

heart

If heart transplantation – 50 years after Christiaan Barnard carried out the first operation – has become routine, what exactly will medicine be capable of in the future? Will we one day be able to build, or even grow, replacement hearts, or will surgeons be able to use genetically modified animal hearts in their place?

New techniques are badly needed because the number of donor organs – about 200 per year in the UK – is dwarfed by demand. About 2,000 people under the age of 65 a year will die of heart failure without a transplant. One option researchers hope to develop is to use stem cells to grow new cardiac muscle.

An alternative to growing new hearts is to refine devices that can keep a patient alive until they can have a transplant. In recent years, the left ventricular assist device (LVAD) – an artificial pump that helps the left side of the heart do its job – has shrunk from a large external piece of kit to a tiny battery-operated device that can be implanted into the chest.

The key to the future is not likely to be any single technology, but a combination of all of them. But if the past 50 years have taught us anything at all, it is that things that seem impossible today will become the medicine of tomorrow.

Read full, original post: What will medicine be able to do with hearts?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-14-at-11.11.06-AM
‘Turbo cancer’ or mRNA cancer cure? Strategies to counter misinformation
ChatGPT Image May 28, 2026, 08_16_38 PM
Viewpoint: Why the EPA mismeasures cancer risk of chemicals and what should be done to fix it
ChatGPT-Image-May-22-2026-10_56_42-AM-2
‘It’s not super useful’: As wariness about AI grows, Trump proposes rollback of healthcare safeguards
fda_logo_decimated
Viewpoint: RFK, Jr.’s FDA is on a screaming downward path—and why it may never recover
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
Screenshot-2026-05-27-at-10.51.25-AM
Viewpoint: ‘Monsanto’ blues—Planned Netflix movie promises yet another round of anti-glyphosate disinformation
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
Screenshot 2025-11-12 at 12.00
‘Biotech Barbie' Manhattan Project: Will CRISPR babies escape the shadow of He Jiankui?
ChatGPT-Image-May-28-2026-11_31_47-AM-2
Relying on your doctor or AI miracle cure, death and debilitation? Neurologist makes the wrong choice
ChatGPT-Image-May-22-2026-10_26_09-AM
Gutting the National Science Board: How the Trump-RFK, Jr. crusade is erasing the separation of science and state

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.